Quetiapine oral suspension - OWP Pharmaceuticals
Alternative Names: Quetiapine fumarate - OWP PharmaceuticalsLatest Information Update: 12 Jul 2023
At a glance
- Originator OWP Pharmaceuticals
- Class Analgesics; Antidepressants; Antipsychotics; Behavioural disorder therapies; Dibenzothiazepines; Mood stabilisers; Piperazines; Small molecules
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Bipolar disorders; Schizophrenia
Most Recent Events
- 12 Jul 2023 Clinical trials in Bipolar disorders in USA (PO) (OWP Pharmaceuticals pipeline, July 2023)
- 12 Jul 2023 Clinical trials in Schizophrenia in USA (PO) (OWP Pharmaceuticals pipeline, July 2023)
- 08 Jul 2021 OWP Pharmaceuticals has patent protection for quetiapine oral liquid suspension in USA